Cargando…
Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients
Background Cystic fibrosis (CF) is a genetic disorder with diverse symptoms. Understanding its genetic basis and prevalence is crucial for effective management and treatment. Objective The study aimed to provide comprehensive insights into the frequency of CF gene mutations, clinical presentations,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653747/ https://www.ncbi.nlm.nih.gov/pubmed/38024076 http://dx.doi.org/10.7759/cureus.48564 |
_version_ | 1785136479729614848 |
---|---|
author | Syed, Asaf Rawat, Anurag Tariq, Umer Bin Haq, Ihteshamul Naz, Beenish Hussain, Abrar Maqsood, Mehdi Rasheed, Arsalan |
author_facet | Syed, Asaf Rawat, Anurag Tariq, Umer Bin Haq, Ihteshamul Naz, Beenish Hussain, Abrar Maqsood, Mehdi Rasheed, Arsalan |
author_sort | Syed, Asaf |
collection | PubMed |
description | Background Cystic fibrosis (CF) is a genetic disorder with diverse symptoms. Understanding its genetic basis and prevalence is crucial for effective management and treatment. Objective The study aimed to provide comprehensive insights into the frequency of CF gene mutations, clinical presentations, and complications among the Pakistani population. Methodology A cohort comprising 892 patients, ranging in age from 18 to more than 40 years, was selected on the basis of clinical and genetic criteria for the diagnosis of CF. Polymerase chain reaction (PCR) was used to look for 34 variants in the CFTR gene in blood samples. Statistical analysis, which included figuring out the number of mutations, the average age of diagnosis, and the genetic diversity of the samples, was performed to analyze the percentage of patients with specific mutations, offering insights into the genetic diversity. Results In our comprehensive analysis of 892 patient samples, 77.47% (n=691) displayed consanguinity, indicating a family history. The prevailing symptoms included chronic cough (88.67%; n=791), recurrent respiratory infections (76.68%; n=684), and fatigue (73.76%; n=658). The major complications comprised pulmonary infections (22%; n=197), cystic fibrosis-related diabetes (21%; n=187), and malabsorption (20%: n=178). A paired t-test revealed a mean difference of 5.750 with a standard deviation of 9.147, a 95% confidence interval from -0.061 to 11.561, a t-value of 2.178 with 11 degrees of freedom, and a two-tailed p-value of 0.052, suggesting a potential trend towards significance. Nevertheless, the asymptotic significance values of 1.000 and 0.998 for both groups indicate no significant difference. Furthermore, the study identified 12 cystic fibrosis gene mutations, with F508del and N1303K being the most prevalent. Conclusion This research revealed significant consanguinity, confirmed typical CF symptoms, and identified common complications and prevalent CFTR gene mutations (with F508del and N1303K being the most common), providing insights for genetic guidance and treatment in the Pakistani community. |
format | Online Article Text |
id | pubmed-10653747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-106537472023-11-09 Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients Syed, Asaf Rawat, Anurag Tariq, Umer Bin Haq, Ihteshamul Naz, Beenish Hussain, Abrar Maqsood, Mehdi Rasheed, Arsalan Cureus Genetics Background Cystic fibrosis (CF) is a genetic disorder with diverse symptoms. Understanding its genetic basis and prevalence is crucial for effective management and treatment. Objective The study aimed to provide comprehensive insights into the frequency of CF gene mutations, clinical presentations, and complications among the Pakistani population. Methodology A cohort comprising 892 patients, ranging in age from 18 to more than 40 years, was selected on the basis of clinical and genetic criteria for the diagnosis of CF. Polymerase chain reaction (PCR) was used to look for 34 variants in the CFTR gene in blood samples. Statistical analysis, which included figuring out the number of mutations, the average age of diagnosis, and the genetic diversity of the samples, was performed to analyze the percentage of patients with specific mutations, offering insights into the genetic diversity. Results In our comprehensive analysis of 892 patient samples, 77.47% (n=691) displayed consanguinity, indicating a family history. The prevailing symptoms included chronic cough (88.67%; n=791), recurrent respiratory infections (76.68%; n=684), and fatigue (73.76%; n=658). The major complications comprised pulmonary infections (22%; n=197), cystic fibrosis-related diabetes (21%; n=187), and malabsorption (20%: n=178). A paired t-test revealed a mean difference of 5.750 with a standard deviation of 9.147, a 95% confidence interval from -0.061 to 11.561, a t-value of 2.178 with 11 degrees of freedom, and a two-tailed p-value of 0.052, suggesting a potential trend towards significance. Nevertheless, the asymptotic significance values of 1.000 and 0.998 for both groups indicate no significant difference. Furthermore, the study identified 12 cystic fibrosis gene mutations, with F508del and N1303K being the most prevalent. Conclusion This research revealed significant consanguinity, confirmed typical CF symptoms, and identified common complications and prevalent CFTR gene mutations (with F508del and N1303K being the most common), providing insights for genetic guidance and treatment in the Pakistani community. Cureus 2023-11-09 /pmc/articles/PMC10653747/ /pubmed/38024076 http://dx.doi.org/10.7759/cureus.48564 Text en Copyright © 2023, Syed et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Genetics Syed, Asaf Rawat, Anurag Tariq, Umer Bin Haq, Ihteshamul Naz, Beenish Hussain, Abrar Maqsood, Mehdi Rasheed, Arsalan Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients |
title | Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients |
title_full | Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients |
title_fullStr | Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients |
title_full_unstemmed | Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients |
title_short | Insights Into Cystic Fibrosis Gene Mutation Frequency, Clinical Findings, and Complications Among Pakistani Patients |
title_sort | insights into cystic fibrosis gene mutation frequency, clinical findings, and complications among pakistani patients |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653747/ https://www.ncbi.nlm.nih.gov/pubmed/38024076 http://dx.doi.org/10.7759/cureus.48564 |
work_keys_str_mv | AT syedasaf insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients AT rawatanurag insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients AT tariqumerbin insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients AT haqihteshamul insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients AT nazbeenish insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients AT hussainabrar insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients AT maqsoodmehdi insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients AT rasheedarsalan insightsintocysticfibrosisgenemutationfrequencyclinicalfindingsandcomplicationsamongpakistanipatients |